Cantor Fitzgerald Starts Illumina (ILMN) at Hold; Sidelined Until Better Visibility

Cantor Fitzgerald initiates coverage on Illumina (NASDAQ: ILMN) with a Hold. PT $35.00.

Cantor analyst says, "While we are confident in Illumina's ability to maintain market leadership and we think there is meaningful growth potential for cutting-edge genetic analysis technologies longer-term, we are less certain that the demand from the research community can continue to keep pace with the rate of the company's NGS technology innovation. As such, we stay on the sidelines and wait for better visibilty on: 1) current end market's capability to absorb excess NGS capacity recently created; 2) demand for the new desktop sequencer; and 3) the rate and level of adoption within other markets, particularly in clinical diagnostics."

For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.

Shares of Illumina closed at $31.43 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• Raymond James Starts SpyGlass Pharma (SGP) at Outperform
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform